Your session is about to expire
← Back to Search
Decision-Making Support for Prostate Cancer Screening (PSA Trial)
N/A
Waitlist Available
Led By Roshan Bastani, PhD
Research Sponsored by Jonsson Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Latino men
Not having BPH (prostate inflammation)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-baseline interview
Awards & highlights
PSA Trial Summary
This trial is testing an intervention to increase inform decision-making in Latino men regarding prostate cancer screening. The intervention is an interactive presentation on prostate cancer, given to small groups of men. The investigators hope that this will increase knowledge of prostate cancer, communication about the disease, and screening rates.
Who is the study for?
This trial is for Latino men aged 50-70 in Los Angeles who have never had prostate cancer or a PSA test in the last year, and do not currently have prostate issues like pain during urination. Men with previous prostate surgery, biopsy, or outside the age range are excluded.Check my eligibility
What is being tested?
The study tests if an interactive session discussing prostate cancer screening can improve decision-making among participants compared to just receiving printed material. The impact on knowledge and screening rates will be assessed through follow-ups.See study design
What are the potential side effects?
Since this trial involves educational sessions rather than medical treatments, there are no direct side effects related to drugs or interventions typically associated with clinical trials.
PSA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a Latino man.
Select...
I do not have prostate inflammation.
Select...
I have never had prostate cancer.
Select...
I do not have prostate issues like pain during urination or frequent urges to urinate.
Select...
I am between 50 and 70 years old.
PSA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months post-baseline interview
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-baseline interview
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Inform Decision-Making
Secondary outcome measures
Prostate cancer knowledge, Receipt of PSA, and Communication with family, friends, and medical providers
PSA Trial Design
2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
Printed material regarding general prostate cancer information provided.
Group II: 1Experimental Treatment1 Intervention
Educational small group session regarding prostate cancer
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Printed Material
2007
N/A
~300
Find a Location
Who is running the clinical trial?
Jonsson Comprehensive Cancer CenterLead Sponsor
359 Previous Clinical Trials
25,069 Total Patients Enrolled
38 Trials studying Prostate Cancer
2,994 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,147 Total Patients Enrolled
560 Trials studying Prostate Cancer
506,167 Patients Enrolled for Prostate Cancer
Roshan Bastani, PhDPrincipal InvestigatorUniversity of California, Los Angeles
4 Previous Clinical Trials
73,407 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a Latino man.I do not have prostate inflammation.I am either under 50 or over 70 years old.I have never had prostate cancer.You have never had a prostate biopsy.You are not of Latino descent.I do not have prostate issues like pain during urination or frequent urges to urinate.I have had prostate cancer before.I have had surgery to remove my prostate.I am experiencing symptoms like pain during urination, blood in my urine, or frequent urination.I am between 50 and 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: 1
- Group 2: 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the criteria for this trial exclude people below 45 years of age?
"The age range of patients eligible for this trial is 50 to 70 years. There are 76 trials available for individuals below the legal age and 1315 studies open to those over 65."
Answered by AI
Would I be eligible to join this research initiative?
"To be considered for this trial, prospective participants must possess a diagnosis of prostate cancer and fall within the age bracket between 50 to 70 years old. The clinical study is aiming to recruit 1006 people."
Answered by AI
Are there any openings for participation in this experiment?
"According to clinicaltrials.gov, this medical trial appears to no longer be actively seeking participants as the last update was July 1st 2022 and it first posted on April 1st 2003. Nevertheless, there are an abundance of other trials that are currently recruiting patients."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger